Basic Information | Post buying leads | Suppliers |
Name |
Toceranib |
EINECS | N/A |
CAS No. | 356068-94-5 | Density | 1.293 |
PSA | 77.23000 | LogP | 3.55570 |
Solubility | N/A | Melting Point |
N/A |
Formula | C22H25FN4O2 | Boiling Point | 596.8±50.0 °C(Predicted) |
Molecular Weight | 396.46 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
PHA-291639;Toceranib [USAN];UNII-59L7Y0530C;5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide; |
The Toceranib, with the CAS registry number 356068-94-5, is also known as PHA-291639. This chemical's molecular formula is C22H25FN4O2 and molecular weight is 396.46. What's more, its IUPAC name is 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide. Its classification code is Treatment of mast cell tumors in dogs. Toceranib is a receptor tyrosine kinase inhibitor and is used in the treatment of canine mast cell tumor also called mastocytoma. It is likely to act mostly through inhibition of the kit tyrosine kinase, though it may also have an anti-angiogenic effect.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)C=C3C4=C(C=CC(=C4)F)NC3=O
(2)Isomeric SMILES: CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O
(3)InChI: InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-
(4)InChIKey: SRSGVKWWVXWSJT-ATVHPVEESA-N